We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.30
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.012%)
Open: 17.30
High: 0.00
Low: 0.00
Prev. Close: 17.30
CPIC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

24 Jun 2020 07:00

RNS Number : 8584Q
UBS AG London Branch
24 June 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

24 June 2020

 

China Pacific Insurance (Group) Co., LTD.

Mid-stabilisation Period Notice 

 

Further to the pre-stabilisation period announcement dated 16 June 2020, UBS AG London Branch (Contact: Francois-Olivier Mercier, Syndicate Desk: +44 20756 87504) hereby gives notice that stabilisation (within the meaning of Commission Delegated Regulation (EU) 2016/1052 supplementing the Market Abuse Regulation (EU) 596/2014) in relation to the offer of the following securities undertook by it or any of its affiliates in accordance with the rules of the Financial Conduct Authority.

 

The securities:

Issuer:

China Pacific Insurance (Group) Co., LTD.

Securities:

Global Depositary Receipts ("GDRs") each representing 5 A shares of the Company

ISIN:

US16951T1198

Offering size:

Institutional Offering: 102,873,300GDRs (excluding the over-allotment option)

Market:

London Stock Exchange plc, Shanghai-London Stock Connect segment

Ticker:

CPIC

Description:

Initial Public Offering of GDRs

Offer price:

US$ 17.60 per GDR

Associated securities:

There are no associated instruments that are subject to stabilisation

Stabilising Manager:

UBS AG London Branch, 5 Broadgate, London. EC2M 2QS 

 

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

 

Trade Date

Lowest price (US$)

Highest price (US$)

Trading Venue

17/06/2020

17.60

17.60

LSE

 

 

Important legal information

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, Japan, South Africa or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer to sell, or solicitation of an offer to buy, acquire or subscribe for any securities to any person in the United States (including its territories and possessions, any state of the United States and the District of Columbia) or in any other jurisdiction in which such offer or solicitation would be unlawful. The GDRs have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any State or other jurisdiction of the United States and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to or an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any applicable state or local securities law. The Company has not intended and does not intend to make any public offer of securities in the United States. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the Company and that will contain detailed information about the Company and management, as well as financial statements.

In any member state of the European Economic Area (the "EEA") (each, a "Relevant Member State"), this announcement and the Offering are only addressed to and directed at persons who are "qualified investors" ("Qualified Investors") within the meaning of the Regulation (EU) 2017/1129 (the "Prospectus Regulation").

In the United Kingdom, this announcement and any offer if made subsequently is only addressed to and directed at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), (ii) high net worth entities who fall within Article 49(2)(a) to (d) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons being referred to as "relevant persons"). This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not relevant persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to and will only be engaged with (i) in the United Kingdom, relevant persons, and (ii) in any member state of the EEA, Qualified Investors and other persons who are permitted to subscribe for the GDRs described herein pursuant to an exemption from the Prospectus Regulation and other applicable legislation, and will only be engaged in with such persons.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAFJMBTMTMTTMM
Date   Source Headline
15th Apr 202410:01 amRNSAnnouncement relating to Premium Income
11th Apr 20249:43 amRNSResignation of a Proposed Supervisor
8th Apr 20247:00 amRNSApproval of Director's Appointment Qualification
28th Mar 20243:58 pmRNSPublication of Summaries of Solvency Reports
28th Mar 20243:51 pmRNSPublication of 2023 Annual Results Presentation
28th Mar 20243:46 pmRNSCPIC 2023 Annual Report
21st Mar 202410:29 amRNSConvening of 2023 Annual Results Presentation
14th Mar 20249:28 amRNSAnnouncement relating to Premium Income
29th Feb 20242:09 pmRNSAnnouncement relating to election and appointment
29th Feb 20242:06 pmRNSAnnouncement on Poll Results for the EGM
29th Feb 20241:42 pmRNSAnnouncement relating to resignation of supervisor
19th Feb 20249:30 amRNSAnnouncement relating to Premium Income
19th Feb 20247:00 amRNSApproval of Director's Appointment Qualification
5th Feb 20249:17 amRNSNotice of EGM
29th Jan 20241:41 pmRNSApproval of Appointment Qualification
29th Jan 20241:34 pmRNSChange of President
29th Jan 20241:31 pmRNSResignation of Chairman of the Board
16th Jan 20249:36 amRNSAnnouncement relating to Premium Income
15th Dec 20238:26 amRNSAnnouncement relating to Premium Income
11th Dec 202310:44 amRNSProposed amendments to the Articles of Association
27th Nov 202311:03 amRNSPoll Results for the EGM
16th Nov 20239:22 amRNSAnnouncement relating to Premium Income
9th Nov 20238:46 amRNSNotice of EGM
9th Nov 20238:37 amRNSPDMR Shareholding
27th Oct 202312:18 pmRNSResignation of Director
27th Oct 202312:11 pmRNSPublication of Summaries of Solvency Reports
27th Oct 202312:01 pmRNSCPIC 2023 Third Quarter Report
20th Oct 202310:33 amRNS2023 Q3 Results Presentation
17th Oct 202311:00 amRNSAnnouncement relating to Premium Income
13th Sep 20239:43 amRNSAnnouncement relating to Premium Income
29th Aug 20237:00 amRNSPublication of Summaries of Solvency Reports
29th Aug 20237:00 amRNSPublication of 2023 Interim Results Presentation
29th Aug 20237:00 amRNS2023 Interim Report
17th Aug 202310:59 amRNSConvening of 2023 Interim Results Presentation
14th Aug 202310:21 amRNSAnnouncement relating to Premium Income
3rd Aug 20239:45 amRNSAppointment of Member of Committees of the Board
21st Jul 20233:03 pmRNSApproval of Director's Appointment Qualification
14th Jul 20239:44 amRNSAnnouncement relating to Premium Income
4th Jul 20237:30 amRNSPDMR Shareholding
3rd Jul 202311:30 amRNSDisclosure of Presentations on 2023 Investor Day
28th Jun 202311:29 amRNSDirector/PDMR Shareholding
28th Jun 202311:26 amRNSDirector/PDMR Shareholding
14th Jun 202310:04 amRNSAnnouncement relating to Premium Income
13th Jun 202310:57 amRNSDirector/PDMR Shareholding
13th Jun 202310:54 amRNSDirector/PDMR Shareholding
13th Jun 202310:53 amRNSDirector/PDMR Shareholding
13th Jun 202310:53 amRNSDirector/PDMR Shareholding
26th May 202311:54 amRNSAnnouncement on Poll Results for the 2022 AGM
12th May 20239:53 amRNSAnnouncement relating to Premium Income
27th Apr 20231:10 pmRNS2023 First Quarter Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.